OrthoPediatrics Corp.

OrthoPediatrics Corp. is a medical device company exclusively focused on designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions. Founded in 2006, the company's mission is to improve the lives of pediatric orthopedic patients. Its headquarters are located in Warsaw, Indiana, USA.

The company offers a comprehensive portfolio of over 70 surgical systems tailored for the unique needs of children, spanning key market segments such as pediatric trauma and deformity correction, scoliosis, and sports medicine. These products are specifically engineered to accommodate the delicate anatomy and developmental stages of young patients, differentiating them from adult-oriented orthopedic solutions. Notable product lines include PediLoc, PediPlates, cannulated screws, and specialized bracing products.

OrthoPediatrics is publicly traded on NASDAQ under the ticker KIDS. David Bailey serves as the President & CEO. The company reported strong financial performance in Q1 2026, with revenue reaching $59.4 million, a 13% year-over-year increase, and adjusted EBITDA improving to $2.2 million. OrthoPediatrics projects 2026 revenue to be between $263 million and $267 million, anticipating 11% to 13% growth over 2025, and expects to achieve approximately $25 million in Adjusted EBITDA and breakeven free cash flow for the full year. In June 2026, the company announced an exclusive distribution agreement with OSSIO, Inc. to provide orthopedic fixation technology to U.S. Children's Hospitals. Its global sales organization distributes products in the United States and over 70 countries worldwide.